Modelling Therapeutic Strategies in the Treatment of Osteoarthritis: An Economic Evaluation of Meloxicam Versus Diclofenac and Piroxicam

Author： Tavakoli M.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.6, 2003-01, pp. : 443-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Nimesulide Versus Diclofenac in the Treatment of Osteoarthritis in Greece

By Liaropoulos L.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 575-588

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Nimesulide versus Diclofenac in the Treatment of Osteoarthritis in France, Italy and Spain

By Tarricone R.  

Clinical Drug Investigation, Vol. 21, Iss. 7, 2001-07 ,pp. : 453-464

Adis International

Access to resources Recommend Favorite

Meloxicam cost saving over piroxicam and diclofenac in OA

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Meloxicam cost saving over piroxicam and diclofenac in OA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 410, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Economic evaluation of osteoarthritis treatment in Europe

By Gillette Jennifer A   Tarricone Rosanna  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 327-341

Informa Healthcare

Access to resources Recommend Favorite